Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Shuhui Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8603-8805; OpenAlex author ID A5000040403. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. MMP1 is a promising prognostic, therapeutic and immunological biomarker for pancreatic cancer: evidence from bioinformatics analysis and biological experiments. Co-author DOI 10.1186/s12885-026-15685-0↗
  2. SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1/miR-133b/SQLE axis. Co-author DOI 10.1111/jcmm.17347↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Cheng · 1 shared paper, 2026 · strength 0.36
  2. Lei Dong · 1 shared paper, 2022 · strength 0.15
  3. Hong Li · 1 shared paper, 2022 · strength 0.15
  4. Jing Zhang · 1 shared paper, 2022 · strength 0.15
  5. Ting Wang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.